Serina Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
HUNTSVILLE, Sept. 04, 2024 (GLOBE NEWSWIRE) — Serina Therapeutics (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary […]